[1] H.A. Rothan, S.N. Byrareddy, The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak, J. Autoimmun. 109 (2020). https://doi.org/10.1016/j.jaut.2020.102433.
[2] S.F. Ahmed, A.A. Quadeer, M.R. McKay, Preliminary identification of potential vaccine targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies, Viruses. 12 (2020). https://doi.org/10.3390/v12030254.
[3] M.T. ul Qamar, S.M. Alqahtani, M.A. Alamri, L.-L. Chen, Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants, J. Pharm. Anal. (2020). https://doi.org/10.1016/j.jpha.2020.03.009.
[4] J. Liu, X. Zheng, Q. Tong, W. Li, B. Wang, K. Sutter, M. Trilling, M. Lu, U. Dittmer, D. Yang, Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV, J. Med. Virol. 92 (2020) 491–494. https://doi.org/10.1002/jmv.25709.
[5] Y.F. Tu, C.S. Chien, A.A. Yarmishyn, Y.Y. Lin, Y.H. Luo, Y.T. Lin, W.Y. Lai, D.M. Yang, S.J. Chou, Y.P. Yang, M.L. Wang, S.H. Chiou, A review of sars-cov-2 and the ongoing clinical trials, Int. J. Mol. Sci. 21 (2020). https://doi.org/10.3390/ijms21072657.
[6] A.A. Rabaan, S.H. Al-Ahmed, S. Haque, R. Sah, R. Tiwari, Y.S. Malik, K. Dhama, M.I. Yatoo, D.K. Bonilla-Aldana, A.J. Rodriguez-Morales, SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview, Le Infez. Med. 28 (2020) 174–184.
[7] B. Shanmugaraj, K. Siriwattananon, K. Wangkanont, W. Phoolcharoen, Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19), Asian Pacific J. Allergy Immunol. 38 (2020) 10–18. https://doi.org/10.12932/AP-200220-0773.
[8] C. Wu, Y. Liu, Y. Yang, P. Zhang, W. Zhong, Y. Wang, Q. Wang, Y. Xu, M. Li, X. Li, M. Zheng, L. Chen, H. Li, Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods, Acta Pharm. Sin. B. (2020). https://doi.org/10.1016/j.apsb.2020.02.008.
[9] Z. Jin, X. Du, Y. Xu, Y. Deng, M. Liu, Y. Zhao, B. Zhang, X. Li, L. Zhang, C. Peng, Y. Duan, J. Yu, L. Wang, K. Yang, F. Liu, R. Jiang, X. Yang, T. You, X. Liu, X. Yang, F. Bai, H. Liu, X. Liu, L.W. Guddat, W. Xu, G. Xiao, C. Qin, Z. Shi, H. Jiang, Z. Rao, H. Yang, Structure of Mpro from COVID-19 virus and discovery of its inhibitors, Nature. (2020). https://doi.org/10.1038/s41586-020-2223-y.
[10] L. Zhang, D. Lin, X. Sun, U. Curth, C. Drosten, L. Sauerhering, S. Becker, K. Rox, R. Hilgenfeld, Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors, Science. 368 (2020) 409–412. https://doi.org/10.1126/science.abb3405.
[11] J. Tan, S. George, Y. Kusov, M. Perbandt, S. Anemuller, J.R. Mesters, H. Norder, B. Coutard, C. Lacroix, P. Leyssen, J. Neyts, R. Hilgenfeld, 3C Protease of Enterovirus 68: Structure-Based Design of Michael Acceptor Inhibitors and Their Broad-Spectrum Antiviral Effects against Picornaviruses, J. Virol. 87 (2013) 4339–4351. https://doi.org/10.1128/jvi.01123-12.
[12] P.S. Dragovich, R. Zhou, D.J. Skalitzky, S.A. Fuhrman, A.K. Patick, C.E. Ford, J.W. Meador, S.T. Worland, Solid-phase synthesis of irreversible human rhinovirus 3C protease inhibitors. Part 1: Optimization of tripeptides incorporating N-terminal amides, in: Bioorganic Med. Chem., Bioorg Med Chem, 1999: pp. 589–598. https://doi.org/10.1016/S0968-0896(99)00005-X.
[13] D.E. Gordon, G.M. Jang, M. Bouhaddou, J. Xu, K. Obernier, K.M. White, M.J. O’meara, V. V Rezelj, J.Z. Guo, D.L. Swaney, T.A. Tummino, R. Huettenhain, R.M. Kaake, A.L. Richards, B. Tutuncuoglu, H. Foussard, J. Batra, K. Haas, M. Modak, M. Kim, P. Haas, B.J. Polacco, H. Braberg, J.M. Fabius, M. Eckhardt, M. Soucheray, M.J. Bennett, M. Cakir, M.J. Mcgregor, Q. Li, B. Meyer, F. Roesch, T. Vallet, A. Mac Kain, L. Miorin, E. Moreno, Z. Zar, C. Naing, Y. Zhou, S. Peng, Y. Shi, Z. Zhang, W. Shen, I.T. Kirby, J.E. Melnyk, J.S. Chorba, K. Lou, S.A. Dai, I. Barrio-Hernandez, D. Memon, C. Hernandez-Armenta, J. Lyu, C.J.P. Mathy, T. Perica, K.B. Pilla, S.J. Ganesan, D.J. Saltzberg, R. Rakesh, X. Liu, S.B. Rosenthal, L. Calviello, S. Venkataramanan, J. Liboy-Lugo, Y. Lin, X.-P. Huang, Y. Liu, S.A. Wankowicz, M. Bohn, M. Safari, F.S. Ugur, C. Koh, N. Sadat Savar, Q.D. Tran, D. Shengjuler, S.J. Fletcher, M.C. O’neal, Y. Cai, J.C.J. Chang, D.J. Broadhurst, S. Klippsten, P.P. Sharp, N.A. Wenzell, D. Kuzuoglu, H.-Y. Wang, R. Trenker, J.M. Young, D.A. Cavero, J. Hiatt, T.L. Roth, U. Rathore, A. Subramanian, J. Noack, M. Hubert, R.M. Stroud, A.D. Frankel, O.S. Rosenberg, K.A. Verba, D.A. Agard, M. Ott, M. Emerman, N. Jura, M. Von Zastrow, E. Verdin, A. Ashworth, O. Schwartz, C. D’enfert, S. Mukherjee, M. Jacobson, H.S. Malik, D.G. Fujimori, T. Ideker, C.S. Craik, S.N. Floor, J.S. Fraser, J.D. Gross, A. Sali, B.L. Roth, D. Ruggero, J. Taunton, T. Kortemme, P. Beltrao, M. Vignuzzi, A. García-Sastre, K.M. Shokat, B.K. Shoichet, N.J. Krogan, A SARS-CoV-2 protein interaction map reveals targets for drug repurposing A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature, Nature. (2020). https://doi.org/10.1038/s41586-020-2286-9.
[14] Protein Preparation Wizard | Schrödinger, (n.d.). https://www.schrodinger.com/protein-preparation-wizard (accessed April 17, 2020).
[15] E. Harder, W. Damm, J. Maple, C. Wu, M. Reboul, J.Y. Xiang, L. Wang, D. Lupyan, M.K. Dahlgren, J.L. Knight, J.W. Kaus, D.S. Cerutti, G. Krilov, W.L. Jorgensen, R. Abel, R.A. Friesner, OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins, J. Chem. Theory Comput. 12 (2016) 281–296. https://doi.org/10.1021/acs.jctc.5b00864.
[16] D. Shivakumar, J. Williams, Y. Wu, W. Damm, J. Shelley, W. Sherman, Prediction of absolute solvation free energies using molecular dynamics free energy perturbation and the opls force field, J. Chem. Theory Comput. 6 (2010) 1509–1519. https://doi.org/10.1021/ct900587b.
[17] J.C. Shelley, A. Cholleti, L.L. Frye, J.R. Greenwood, M.R. Timlin, M. Uchimaya, Epik: A software program for pKa prediction and protonation state generation for drug-like molecules, J. Comput. Aided. Mol. Des. 21 (2007) 681–691. https://doi.org/10.1007/s10822-007-9133-z.
[18] S.L. Dixon, A.M. Smondyrev, E.H. Knoll, S.N. Rao, D.E. Shaw, R.A. Friesner, PHASE: A new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results, J. Comput. Aided. Mol. Des. 20 (2006) 647–671. https://doi.org/10.1007/s10822-006-9087-6.
[19] N.K. Salam, R. Nuti, W. Sherman, Novel method for generating structure-based pharmacophores using energetic analysis, J. Chem. Inf. Model. 49 (2009) 2356–2368. https://doi.org/10.1021/ci900212v.
[20] T.A. Halgren, R.B. Murphy, R.A. Friesner, H.S. Beard, L.L. Frye, W.T. Pollard, J.L. Banks, Glide: A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening, J. Med. Chem. 47 (2004) 1750–1759. https://doi.org/10.1021/jm030644s.
[21] C.A. Lipinski, Lead- and drug-like compounds: The rule-of-five revolution, Drug Discov. Today Technol. 1 (2004) 337–341. https://doi.org/10.1016/j.ddtec.2004.11.007.
[22] C.A. Lipinski, F. Lombardo, B.W. Dominy, P.J. Feeney, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings, Adv. Drug Deliv. Rev. 46 (2001) 3–26. https://doi.org/10.1016/S0169-409X(00)00129-0.
[23] M. Karplus, J.A. McCammon, Molecular dynamics simulations of biomolecules, Nat. Struct. Biol. 9 (2002) 646–652. https://doi.org/10.1038/nsb0902-646.
[24] J.A. McCammon, B.R. Gelin, M. Karplus, Dynamics of folded proteins, Nature. 267 (1977) 585–590. https://doi.org/10.1038/267585a0.
[25] M. Arnittali, A.N. Rissanou, V. Harmandaris, Structure of Biomolecules Through Molecular Dynamics Simulations, in: Procedia Comput. Sci., Elsevier B.V., 2019: pp. 69–78. https://doi.org/10.1016/j.procs.2019.08.181.
[26] T.S. Lee, D.S. Cerutti, D. Mermelstein, C. Lin, S. Legrand, T.J. Giese, A. Roitberg, D.A. Case, R.C. Walker, D.M. York, GPU-Accelerated Molecular Dynamics and Free Energy Methods in Amber18: Performance Enhancements and New Features, J. Chem. Inf. Model. 58 (2018) 2043–2050. https://doi.org/10.1021/acs.jcim.8b00462.
[27] A.W. Götz, M.J. Williamson, D. Xu, D. Poole, S. Le Grand, R.C. Walker, Routine microsecond molecular dynamics simulations with AMBER on GPUs. 1. generalized born, J. Chem. Theory Comput. 8 (2012) 1542–1555. https://doi.org/10.1021/ct200909j.
[28] V. Hornak, R. Abel, A. Okur, B. Strockbine, A. Roitberg, C. Simmerling, Comparison of multiple amber force fields and development of improved protein backbone parameters, Proteins Struct. Funct. Genet. 65 (2006) 712–725. https://doi.org/10.1002/prot.21123.
[29] J. Wang, R.M. Wolf, J.W. Caldwell, P.A. Kollman, D.A. Case, Development and testing of a general Amber force field, J. Comput. Chem. 25 (2004) 1157–1174. https://doi.org/10.1002/jcc.20035.
[30] J. Wang, W. Wang, P.A. Kollman, D.A. Case, Automatic atom type and bond type perception in molecular mechanical calculations, J. Mol. Graph. Model. 25 (2006) 247–260. https://doi.org/10.1016/j.jmgm.2005.12.005.
[31] M.F. Harrach, B. Drossel, Structure and dynamics of TIP3P, TIP4P, and TIP5P water near smooth and atomistic walls of different hydroaffinity, J. Chem. Phys. 140 (2014) 174501. https://doi.org/10.1063/1.4872239.
[32] M.J. Harvey, G. De Fabritiis, An implementation of the smooth particle mesh Ewald method on GPU hardware, J. Chem. Theory Comput. (2009). https://doi.org/10.1021/ct900275y.
[33] J.P. Ryckaert, G. Ciccotti, H.J.C. Berendsen, Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes, J. Comput. Phys. (1977). https://doi.org/10.1016/0021-9991(77)90098-5.
[34] Y. Lin, D. Pan, J. Li, L. Zhang, X. Shao, Application of Berendsen barostat in dissipative particle dynamics for nonequilibrium dynamic simulation, J. Chem. Phys. 146 (2017). https://doi.org/10.1063/1.4978807.
[35] D.R. Roe, T.E. Cheatham, PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data, J. Chem. Theory Comput. 9 (2013) 3084–3095. https://doi.org/10.1021/ct400341p.
[36] E. Seifert, OriginPro 9.1: Scientific data analysis and graphing software - Software review, J. Chem. Inf. Model. 54 (2014) 1552. https://doi.org/10.1021/ci500161d.
[37] H. Wan, J.P. Hu, X.H. Tian, S. Chang, Molecular dynamics simulations of wild type and mutants of human complement receptor 2 complexed with C3d, Phys. Chem. Chem. Phys. 15 (2013) 1241–1251. https://doi.org/10.1039/c2cp41388d.
[38] S. Chang, J.P. Hu, P.Y. Lin, X. Jiao, X.H. Tian, Substrate recognition and transport behavior analyses of amino acid antiporter with coarse-grained models, Mol. Biosyst. 6 (2010) 2430–2438. https://doi.org/10.1039/c005266c.
[39] Z. Fakhar, T. Govender, G.E.M. Maguire, G. Lamichhane, R.C. Walker, H.G. Kruger, B. Honarparvar, Differential flap dynamics in l,d-transpeptidase2 from mycobacterium tuberculosis revealed by molecular dynamics, Mol. Biosyst. 13 (2017) 1223–1234. https://doi.org/10.1039/c7mb00110j.
[40] C.C. David, D.J. Jacobs, Principal component analysis: A method for determining the essential dynamics of proteins, Methods Mol. Biol. 1084 (2014) 193–226. https://doi.org/10.1007/978-1-62703-658-0_11.
[41] R.M. Levy, A.R. Srinivasan, W.K. Olson, J.A. McCammon, Quasi‐harmonic method for studying very low frequency modes in proteins, Biopolymers. 23 (1984) 1099–1112. https://doi.org/10.1002/bip.360230610.
[42] J. Chen, J. Wang, W. Zhu, Binding modes of three inhibitors 8CA, F8A and I4A to A-FABP studied based on molecular dynamics simulation, PLoS One. 9 (2014). https://doi.org/10.1371/journal.pone.0099862.
[43] M. Laberge, T. Yonetani, Molecular dynamics simulations of hemoglobin a in different states and bound to DPG: Effector-linked perturbation of tertiary conformations and HbA concerted dynamics, Biophys. J. 94 (2008) 2737–2751. https://doi.org/10.1529/biophysj.107.114942.
[44] T. Ichiye, M. Karplus, Collective motions in proteins: A covariance analysis of atomic fluctuations in molecular dynamics and normal mode simulations, Proteins Struct. Funct. Bioinforma. 11 (1991) 205–217. https://doi.org/10.1002/prot.340110305.
[45] W. Humphrey, A. Dalke, K. Schulten, VMD: Visual molecular dynamics, J. Mol. Graph. 14 (1996) 33–38. https://doi.org/10.1016/0263-7855(96)00018-5.
[46] E. Wang, H. Sun, J. Wang, Z. Wang, H. Liu, J.Z.H. Zhang, T. Hou, End-Point Binding Free Energy Calculation with MM/PBSA and MM/GBSA: Strategies and Applications in Drug Design, Chem. Rev. 119 (2019) 9478–9508. https://doi.org/10.1021/acs.chemrev.9b00055.
[47] H. Gohlke, C. Kiel, D.A. Case, Insights into protein-protein binding by binding free energy calculation and free energy decomposition for the Ras-Raf and Ras-RalGDS complexes., J. Mol. Biol. 330 (2003) 891–913. https://doi.org/10.1016/S0022-2836(03)00610-7.
[48] J. Weiser, P.S. Shenkin, W.C. Still, Approximate atomic surfaces from linear combinations of pairwise overlaps (LCPO), J. Comput. Chem. 20 (1999) 217–230. https://doi.org/10.1002/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A.
[49] A.R. Leach, V.J. Gillet, R.A. Lewis, R. Taylor, Three-dimensional pharmacophore methods in drug discovery, J. Med. Chem. 53 (2010) 539–558. https://doi.org/10.1021/jm900817u.
[50] R.A. Friesner, R.B. Murphy, M.P. Repasky, L.L. Frye, J.R. Greenwood, T.A. Halgren, P.C. Sanschagrin, D.T. Mainz, Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes, J. Med. Chem. 49 (2006) 6177–6196. https://doi.org/10.1021/jm051256o.
[51] S. Khan, I. Bjij, M.E.S. Soliman, Selective Covalent Inhibition of “Allosteric Cys121” Distort the Binding of PTP1B Enzyme: A Novel Therapeutic Approach for Cancer Treatment, Cell Biochem. Biophys. 77 (2019) 203–211. https://doi.org/10.1007/s12013-019-00882-5.
[52] S. Khan, I. Bjij, R.M. Betz, M.E.S. Soliman, Reversible versus irreversible inhibition modes of ERK2: A comparative analysis for ERK2 protein kinase in cancer therapy, Future Med. Chem. 10 (2018) 1003–1015. https://doi.org/10.4155/fmc-2017-0275.
[53] A. Fornili, F. Autore, N. Chakroun, P. Martinez, F. Fraternali, Protein-water interactions in MD simulations: POPS/POPSCOMP solvent accessibility analysis, solvation forces and hydration sites, Methods Mol. Biol. 819 (2012) 375–392. https://doi.org/10.1007/978-1-61779-465-0_23.
[54] H. Chen, A.Z. Panagiotopoulos, Molecular modeling of surfactant micellization using solvent-accessible surface area, Langmuir. 35 (2019) 2443–2450. https://doi.org/10.1021/acs.langmuir.8b03440.
[55] T. Mohammad, S. Batra, R. Dahiya, M.H. Baig, I.A. Rather, J.J. Dong, I. Hassan, Identification of high-affinity inhibitors of cyclin-dependent kinase 2 towards anticancer therapy, Molecules. 24 (2019). https://doi.org/10.3390/molecules24244589.
[56] H.M. Kumalo, S. Bhakat, M.E. Soliman, Investigation of flap flexibility of β-secretase using molecular dynamic simulations, J. Biomol. Struct. Dyn. 34 (2016) 1008–1019. https://doi.org/10.1080/07391102.2015.1064831.
[57] B. Nizami, D. Sydow, G. Wolber, B. Honarparvar, Molecular insight on the binding of NNRTI to K103N mutated HIV-1 RT: Molecular dynamics simulations and dynamic pharmacophore analysis, Mol. Biosyst. 12 (2016) 3385–3395. https://doi.org/10.1039/c6mb00428h.